
1. General Information
EUVIFOL-HP 150 IU Injection is a prescription fertility medicine containing urofollitropin (FSH) 150 IU. It belongs to the gonadotropin/hormonal class and is primarily used for ovarian stimulation in women experiencing certain forms of infertility. It may also be used during assisted reproductive procedures such as IVF under specialist supervision.
The product is supplied as a lyophilized preparation and may require reconstitution before administration, according to the product instructions and healthcare professional's directions.
2. Product Information
Brand: EUVIFOL-HP
Strength: 150 IU
Active ingredient: Urofollitropin
Hormone: Follicle-Stimulating Hormone (FSH)
Dosage form: Powder for injection
Pack: Typically 1 vial; packaging may vary by market
Therapeutic category: Fertility medicine / gonadotropin
Primary application: Ovarian stimulation and female infertility treatment
Route: Subcutaneous or intramuscular administration may be used according to the prescribed product and clinical protocol.
3. Uses of EUVIFOL-HP 150 IU Injection
EUVIFOL-HP 150 IU Injection may be prescribed for:
Treatment of certain causes of female infertility associated with ovulation problems.
Stimulation of ovarian follicles in women who do not ovulate adequately.
Controlled ovarian stimulation as part of IVF and other assisted reproductive technologies (ART).
Development of multiple follicles when clinically appropriate for fertility treatment.
Treatment should be individually planned and monitored by a fertility specialist.
4. Benefits of This Medicine
When appropriately prescribed, urofollitropin may:
Stimulate the development and maturation of ovarian follicles.
Support follicular growth in women with certain ovulatory disorders.
Help produce multiple mature follicles during assisted reproductive treatment.
Support controlled ovarian stimulation before procedures such as egg retrieval in IVF.
The medicine does not guarantee pregnancy, and treatment success depends on several individual and clinical factors.
5. Side Effects of EUVIFOL-HP 150 IU Injection
Possible adverse effects can include:
Injection-site pain, redness, irritation, or swelling
Headache
Nausea
Vomiting
Abdominal or stomach discomfort
Ovarian enlargement
A particularly important complication of gonadotropin treatment is ovarian hyperstimulation syndrome (OHSS). Severe abdominal pain, marked abdominal swelling, rapid weight gain, breathing difficulty, or reduced urination require prompt medical attention.
6. Common Side Effects
Commonly reported effects may include:
Headache
Nausea
Vomiting
Abdominal/stomach pain or discomfort
Pain or irritation at the injection site
Injection-site swelling or redness
Individual reactions vary, so patients should report persistent or troublesome symptoms to their healthcare provider.
7. How to Use EUVIFOL-HP 150 IU Injection
EUVIFOL-HP should be used only according to the fertility specialist's prescription.
The exact dose and treatment schedule are individualized.
Ovarian response is generally monitored during treatment using clinical assessment and appropriate tests such as ultrasound.
The vial may need to be reconstituted with the supplied diluent before administration, depending on the specific pack.
Administration may be subcutaneous or intramuscular according to the prescribed formulation and medical instructions.
Do not change the dose or frequency yourself.
Do not use a prepared solution beyond the period specified in the product instructions.
Because fertility treatment requires careful monitoring, patients should not self-administer the medicine unless their healthcare professional has specifically trained and authorized them to do so.
8. How EUVIFOL-HP 150 IU Works
EUVIFOL-HP contains urofollitropin, a purified form of follicle-stimulating hormone (FSH). FSH acts directly on the ovaries and stimulates the growth and development of ovarian follicles.
As follicles develop, estrogen production increases and the follicles can mature toward the stage required for ovulation or egg retrieval during assisted reproductive treatment.
9. Safety Advice for EUVIFOL-HP 150 IU Injection
Prescription medicine: Use only under the supervision of a qualified fertility specialist.
Pregnancy: This medicine is not intended to be used during pregnancy.
Breastfeeding: Tell your doctor if you are breastfeeding before treatment.
Ovarian conditions: Inform your doctor about ovarian cysts, ovarian disorders, or previous ovarian hyperstimulation.
Hormonal disorders: Inform your doctor about thyroid, adrenal, pituitary, or other significant hormonal conditions.
Abnormal bleeding: Unexplained vaginal bleeding should be evaluated before treatment.
Allergies: Do not use if you have a known allergy to urofollitropin or any component of the formulation.
Monitoring: Regular medical monitoring is important because excessive ovarian stimulation can occur.
Storage: Depending on the specific product pack, storage requirements may include refrigeration at 2–8°C; follow the manufacturer's label and do not freeze unless the official product information specifically permits it.
10. Frequently Asked Questions (FAQs)
Q1. What is EUVIFOL-HP 150 IU Injection used for?
It is a fertility medicine used primarily for ovarian stimulation in women with certain infertility problems and during assisted reproductive procedures such as IVF.
Q2. What is the active ingredient in EUVIFOL-HP 150 IU?
The active ingredient is urofollitropin 150 IU, a purified form of FSH.
Q3. Does EUVIFOL-HP cause ovulation?
Urofollitropin primarily stimulates follicular development. A separate medication, commonly hCG in appropriate treatment protocols, may be used to trigger ovulation when clinically indicated.
Q4. Can EUVIFOL-HP be used for IVF?
Yes. Urofollitropin can be used for controlled ovarian stimulation as part of IVF and other assisted reproductive techniques.
Q5. Can I use EUVIFOL-HP without a prescription?
No. It is a prescription fertility medicine requiring appropriate medical supervision.
Q6. What are the common side effects?
Headache, nausea, vomiting, abdominal discomfort, and injection-site reactions may occur.
Q7. What is the major risk associated with ovarian stimulation?
One important risk is ovarian hyperstimulation syndrome (OHSS). Prompt medical assessment is necessary if severe abdominal symptoms, rapid weight gain, breathing difficulty, or significant swelling develops.
Q8. How should EUVIFOL-HP be stored?
Some product information specifies refrigeration at 2–8°C and protection from freezing. Always follow the storage instructions printed on the particular manufacturer's package.
Q9. Can I replace EUVIFOL-HP with another fertility injection?
Only after consultation with the prescribing fertility specialist. The replacement should match the appropriate active ingredient, strength, dosage form, and clinical indication.
11. Substitutes for EUVIFOL-HP 150 IU Injection
Potential alternatives listed by pharmacy sources include Foligest 150 IU Injection, Neogentin 150 Injection, and Ftrop 150 IU Injection. Availability and formulation can vary by country and manufacturer.
Other urofollitropin 150 IU products may also be available in different markets. A substitute should not be selected solely on brand name or price; the prescribing doctor should confirm that the active ingredient, strength, formulation, and treatment purpose are appropriate.
12. SEO Keywords
EUVIFOL-HP 150 IU Injection exporter from India
EUVIFOL-HP 150 IU Injection supplier India
EUVIFOL-HP 150 IU wholesale supplier
EUVIFOL-HP 150 IU pharmaceutical exporter
EUVIFOL-HP 150 IU medicine exporter Nagpur
Urofollitropin 150 IU Injection exporter
Urofollitropin 150 IU supplier from India
Urofollitropin injection wholesale
Urofollitropin FSH injection supplier
150 IU fertility injection exporter
female infertility injection supplier India
ovarian stimulation injection supplier
fertility medicines exporter from India
IVF fertility injection supplier India
fertility medicine wholesale exporter
pharmaceutical exporter Nagpur India
EUVIFOL-HP supplier USA
EUVIFOL-HP supplier UK
EUVIFOL-HP supplier Australia
EUVIFOL-HP supplier Singapore
EUVIFOL-HP supplier Canada
EUVIFOL-HP supplier South Korea
EUVIFOL-HP supplier UAE
Urofollitropin 150 IU global supplier
genuine fertility medicines exporter from India
prescription fertility medicine exporter India
Keywords







